These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31765388)

  • 1. Assessment of transmission in areas of uncertain endemicity for lymphatic filariasis in Brazil.
    Xavier A; Oliveira H; Aguiar-Santos A; Barbosa Júnior W; da Silva E; Braga C; Bonfim C; Medeiros Z
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007836. PubMed ID: 31765388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia.
    Sime H; Gass KM; Mekasha S; Assefa A; Woyessa A; Shafi O; Meribo K; Kebede B; Ogoussan K; Pelletreau S; Bockarie MJ; Kebede A; Rebollo MP
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006325. PubMed ID: 29579038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of alternative surveillance approaches for lymphatic filariasis in low prevalence settings: Implications for post-validation settings.
    Riches N; Badia-Rius X; Mzilahowa T; Kelly-Hope LA
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008289. PubMed ID: 32396575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
    Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lymphatic filariasis in endemic area of Brazil where mass drug administration is not required.
    Silva E; Xavier A; Silva E; Barbosa Júnior W; Rocha A; Freitas V; Oliveira P; Aguiar-Santos AM; Bonfim C; Medeiros Z
    Pathog Glob Health; 2019 May; 113(3):143-148. PubMed ID: 31138026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
    Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration.
    Modi A; Vaishnav KG; Kothiya K; Alexander N
    Infect Dis Poverty; 2021 May; 10(1):73. PubMed ID: 34006319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
    Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
    Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
    de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Expanded Transmission Assessment Survey to Confirm the Interruption of Lymphatic Filariasis Transmission in Wallis and Futuna.
    Pezzoli L; Kim SH; Mathelin JP; Hennessey K; Eswara Aratchige P; Valiakolleri J
    Am J Trop Med Hyg; 2019 Dec; 101(6):1325-1330. PubMed ID: 31595868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
    Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
    Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
    Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
    Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis.
    Harris JR; Wiegand RE
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005610. PubMed ID: 28542274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation.
    Chu BK; Deming M; Biritwum NK; Bougma WR; Dorkenoo AM; El-Setouhy M; Fischer PU; Gass K; Gonzalez de Peña M; Mercado-Hernandez L; Kyelem D; Lammie PJ; Flueckiger RM; Mwingira UJ; Noordin R; Offei Owusu I; Ottesen EA; Pavluck A; Pilotte N; Rao RU; Samarasekera D; Schmaedick MA; Settinayake S; Simonsen PE; Supali T; Taleo F; Torres M; Weil GJ; Won KY
    PLoS Negl Trop Dis; 2013; 7(12):e2584. PubMed ID: 24340120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic filariasis in Brazil: epidemiological situation and outlook for elimination.
    Fontes G; Leite AB; de Lima AR; Freitas H; Ehrenberg JP; da Rocha EM
    Parasit Vectors; 2012 Nov; 5():272. PubMed ID: 23181663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.
    Mwakitalu ME; Malecela MN; Pedersen EM; Mosha FW; Simonsen PE
    Acta Trop; 2013 Dec; 128(3):692-700. PubMed ID: 24135628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of 'transmission assessment surveys' (TAS) for the lymphatic filariasis elimination program.
    Dewi RM; Tuti S; Ganefa S; Anwar C; Larasati R; Ariyanti E; Herjati H; Brady M
    Parasit Vectors; 2015 Oct; 8():499. PubMed ID: 26427536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.